Clinical Trials Directory

Trials / Completed

CompletedNCT04455256

Evaluation of Endoplasmic Reticulum Stress in Patients With Recurrent Pregnancy Loss

Endoplasmic Reticulum Stress in Recurrent Pregnancy Loss

Status
Completed
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
Kanuni Sultan Suleyman Training and Research Hospital · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

To evaluate endoplasmic reticulum stress in women with recurrent pregnancy loss and those who had healthy births in the same age group. The level of the unfolded protein X box binding protein 1 (XBP-1) is measured. It is aimed to show the effect of endoplasmic reticulum stress on recurrent pregnancy loss.

Conditions

Interventions

TypeNameDescription
OTHERx box binding proteinSerum value (pg / mL) of x box binding protein (XBP-1), which is one of the unfolded proteins indicating endoplasmic reticulum stress, is measured.

Timeline

Start date
2020-03-20
Primary completion
2020-07-01
Completion
2020-07-07
First posted
2020-07-02
Last updated
2020-07-16

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04455256. Inclusion in this directory is not an endorsement.

Evaluation of Endoplasmic Reticulum Stress in Patients With Recurrent Pregnancy Loss (NCT04455256) · Clinical Trials Directory